Use and application of a pharmaceutical composition containing a mixture of natural- origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies

a technology of heterocyclic guanidine and composition, which is applied in the field of pharmaceutical compositions containing heterocyclic guanidinetype compounds, can solve the problems of social groups judging the appearance of wrinkles on the neck and face of people as negative, complicated use and handling, and less desirable effects

Inactive Publication Date: 2006-06-08
PHYTOTOX LTD
View PDF42 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0007] In accordance with the objects of the invention, novel compositions and methods are provided. In one aspect of the invention, pharmaceutical co

Problems solved by technology

The presence of wrinkles in the neck and face of people are seen as negative aesthetic effects by social groups.
While Botulin A toxin is effective as a facial rejuvenate, it is an enzyme that is inherently unstable.
This instability makes its use and h

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use and application of a pharmaceutical composition containing a mixture of natural- origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
  • Use and application of a pharmaceutical composition containing a mixture of natural- origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies

Examples

Experimental program
Comparison scheme
Effect test

example

[0022] Before the application, a photographic record is made of the person to be treated, first with her face resting and relaxed, and then, frowning and producing a maximum facial contraction. The person then places ice on their forehead and on the two lateral zones where the preparation is to be injected. With reference to FIG. 2, the application should follow a specific pattern. A volume is injected alongside each black-dot injection point shown in FIG. 2. A pharmaceutical composition comprising a (2:1:1 volume / volume) mixture of Gonyautoxin 2, Gonyautoxin 3 and Saxitoxin mixture is applied at a dose of 40 units / milliliter. Each injection is made with a 1 milliliter, tuberculin-type disposable syringe with a 27-30 gauge needle. After injecting, the point of injection is disinfected with a gauze soaked in bi-alcohol or in any other disinfectant. The total amount required to complete the face treatment is 1.7 milliliters.

[0023] The expected result is an immediate inability to frow...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Volumeaaaaaaaaaa
Volumeaaaaaaaaaa
Compositionaaaaaaaaaa
Login to view more

Abstract

Pharmaceutical compositions comprising tricyclic 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission are provided.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application claims priority under the Paris Convention for the Protection of Industrial Property to Chilean Patent Application Number 2764-2001, filed on Nov. 15, 2001 in the Department of Industrial Property in the Republic of Chile. STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT [0002] Not applicable. REFERENCE TO MICROFICHE APPENDIX [0003] Not applicable. FIELD OF THE INVENTION [0004] This invention relates to pharmaceutical compositions containing heterocyclic guanidine-type compounds and uses thereof for blocking neuronal transmission. More specifically, this invention relates to tricyclic 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission. BACKGROUND OF THE INVENTION [0005] The presence of wrinkles in the neck and face of people are seen as negative aesthetic effects by social groups. These marks reflect face aging and increase the subjective awareness of the age of people. Since t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/519A61KC07D473/32A61K9/08A61K9/10A61K31/505A61K31/52A61K35/74A61K38/00A61K38/48A61K47/04A61K47/12A61P17/00A61P21/02A61P25/00C07D
CPCA61K31/519A61K31/52A61K38/4886A61K2300/00A61K31/495A61K31/40A61K31/4168A61P1/00A61P13/10A61P17/00A61P17/02A61P21/00A61P21/02A61P25/00A61P27/02A61P29/00
Inventor WILSON, NESTOR ANTONIO LAGOS
Owner PHYTOTOX LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap